Children with type 1 diabetes (T1D) susceptibility HLA genotypes are shown to have an increased birthweight. We investigated to what extent T1D-predisposing HLA haplotypes were associated with increased birthweight. A total of 1255 Finnish children comprising those with T1D and their non-diabetic siblings were investigated. A total of 342 children and their non-diabetic parents were HLA genotyped. Birthweight data were obtained from the national Medical Birth Registry. The population-specific diabetogenic haplotype HLA-A2,Cw1,B56,DR4,DQ8 was associated with high birthweight (P ¼ 0.0280) in families with a diabetic offspring. Other T1D-predisposing HLA haplotypes showed nonsignificant tendency with high birthweight. More infants with a birthweight X4000 g were born in families with a T1D offspring than in the general Finnish population (P ¼ 0.0139). The previously observed direct association between birthweight and T1D risk may be mediated through the modulating effects that T1D susceptibility HLA genes have on weight. High birthweight and subsequent weight gain may accelerate the ongoing pancreatic autoimmune process in genetically susceptible individuals. The high proportion of infants having a birthweight X4000 g in families with a diabetic offspring raises a concern of potential adverse health outcomes that high birthweight can have.
Introduction
Type 1 diabetes (T1D) is a chronic, multifactorial disease, in which insulin-producing b-cells of pancreatic islets are partly or completely destroyed by an immune-mediated mechanism. 1 The incidence of T1D is increasing worldwide, with an especially rapid rise in the age group of under 5-year-olds. 2, 3 In Finland, the incidence is highest in the world, over 60/100 000 cases per year (Harjutsalo, personal communication) , that is, already exceeding the previous prediction of 50/100 000 cases per year for the year 2010. 3 Both genetic and environmental factors are involved in the pathogenesis of T1D. The major genetic susceptibility for T1D lies within the HLA region on chromosome 6p, especially on DR and DQ loci. 4 Also many other loci have been implicated to confer susceptibility to T1D, but their contribution to the risk is much smaller than that of HLA genes. 4 In North Europe, HLA haplotypes [A1,Cw7,B8, DR3,DQ2], [A2,Cw3,B62,DR4,DQ8] and [A24,Cw7,B39, DR4,DQ8] predispose strongly to T1D, whereas haplotypes [A3,Cw4,B35,DR1] and [A3,Cw7,B7,DR2] are reduced in T1D patients and considered as 'protective'. 5, 6 In Finland, a specific haplotype [A2,Cw1,B56,DR4,DQ8] that increases the risk of T1D only in the Finnish population has been identified. 5 It is the third most common susceptibility haplotype and the most common one transmitted from a diabetic parent to the T1D offspring. 5 It also carries the highest haplotype-specific risk for T1D. 6 The [Cw1,B56,DR4,DQ8] haplotype is conserved, associating only with HLA alleles A2, A1, A3 and A11; alleles other than A2 are, however, infrequently found in individuals with T1D. 7 It has been claimed that the proportion of Finnish T1D patients with a non-susceptibility HLA haplotype is presently higher than that in the 1960s, 8 suggesting a reduced genetic susceptibility in the disease pathogenesis.
A continuous increase in the incidence of T1D over a relatively short time period implies a changing role of environmental factors and/or gene-environment interaction. Various environmental factors, altered perinatal growth factors among others, have been suggested to predispose to T1D. 9, 10 If perinatal factors are important in the development of T1D, their influence is likely to be greatest among early-onset cases. 11 It is not clear whether high (X4000 g) or low (p2500 g) birthweight (BW) increases the risk of T1D or whether no association exists between BW and T1D. [12] [13] [14] [15] [16] [17] Findings from recent epidemiological studies suggest an association between high BW and an increased risk of T1D, especially in children with a BW of 4000 g or more. 14, 15 It has also been shown that infants born large for gestational age have an increased risk of T1D. 18 However, these associations may be restricted only to cases with disease onset at young age. 19 Although there is some evidence suggesting a role for HLA genes in fetal growth, data on possible association between HLA genes and BW are restricted mainly to special cases. 20 Moreover, it has been debated whether some T1D-associated HLA genes are also associated with increased BW. A direct association between BW and the non-susceptibility HLA-DR13 allele group has been found in Finland; full-term infants carrying DR13 born to non-diabetic mothers had a higher BW than those without DR13. 21 This observation was confirmed by reports on the association of high BW and non-susceptibility DQB1*0603 allele, which has a strong linkage disequilibrium with DR13. 22, 23 One study showed strong associations between the T1D susceptibility HLA-DQ2/8, DQ8/0604 and DQ8/X genotypes and high BW, 22 and the association for the DQ2/8 genotype has been replicated recently. 23 The presence of DQ8-linked DR4 alleles has also been associated with increased BW in children born to mothers with T1D, but not in those born to nondiabetic mothers. 24 However, an inverse relationship between T1D susceptibility genotypes and BW has also been observed, 25 and a recent study reported no evidence for interaction between HLA and BW, although children with the non-susceptibility DQB1*0602 allele tended to be heavier at birth. 17 The aim of the study was to evaluate whether T1D-associated HLA haplotypes were associated with BW among Finnish families with a T1D offspring. The mean BWs of children in families with a T1D offspring and in the general population were compared. We also compared the prevalence of newborns with a BW X4000 g in these T1D families with that among the Finnish newborns in general. (Table 2) .
Results

Based on the
When comparing the HLA alleles separately with analysis of variance, only the HLA-B56 allele was associated with increased BW (P ¼ 0.0086). Children with the B56 allele had a significantly higher mean BW than children without the allele (3960 g, s. . Children carrying either DR8 or DR13 were not significantly heavier compared to children without these alleles. The proportion of children with and without T1D susceptibility alleles DR3, DR4 and DR8, or non-susceptibility alleles DR2 (that is, DR15 and DR16) and DR13 did not significantly differ between the three weight groups, while B56 allele was more often observed in the highest BW group (data not shown).
Proportion of children having a BW greater than 4000 g In families with a T1D offspring, 22.6% out of 1255 of children had a BW X4000 g (Figure 1 ), whereas in the general Finnish population the proportion of newborns with a BW X4000 g was 19.8% (P ¼ 0.0139 for difference). During 1987À1999, the proportion of infants weighing X4000 g decreased in the general Finnish population (P ¼ 0.0032), but such a trend was not observed among families with a T1D offspring. 26 Altogether, 342 children born at gestational weeks 37À42 were genotyped. N is the number of children having a particular haplotype. 22, 23 implicating possible role for HLA genes or HLA-linked genes in intrauterine growth. We also showed that the proportion of infants with a BW X4000 g was higher in families with a T1D offspring than among infants in the general Finnish population.
Only few studies exist on the association between T1D susceptibility HLA genes and BW, with conflicting results, which may be due to different study designs. 17, [21] [22] [23] [24] [25] Our present findings implicate that the T1D susceptibility haplotypes may modify fetal development. Alterations in fetal growth are known to associate with T1D in various ways. 9 Our finding is particularly interesting, since we show that the [B56,DR4] haplotype, which strongly increases the T1D risk in Finland, but has not been found in T1D patients outside this country, 5, 6 is associated with high BW. At the present, we do not have data on BW in non-diabetic individuals without a family history of T1D who carry the [B56,DR4] haplotype. Although there were non-diabetic siblings with high BW who carried the [B56,DR4] haplotype, they may develop T1D later on, since this haplotype seems to have a very high penetrance. 5 In accordance with previous studies, 17, 21, 25 we showed that children with a non-susceptibility DR13 allele, linked to the DQB1*0603 allele, and also those with the [B35,DR1] haplotype tend to be heavier at birth compared to children without these alleles or haplotypes. We also showed that children carrying the T1D susceptibility allele DR8 were somewhat heavier at birth than children without the allele, opposite to a previous Finnish report. 21 However, this previous study did not target the families with a T1D offspring, whereas our study comprised children with T1D and their thus far unaffected siblings. The observed difference between these studies may indicate that there is an interaction between HLA genes and BW in the risk of developing T1D.
As suggested before, 22 we have now confirmed that the observed association between T1D and high BW is partly due to the combined effects HLA genes have on both the disease progression and fetal growth. High BW that may result from having certain HLA genes or haplotypes does not cause T1D per se, but may accelerate the disease progression in these genetically susceptible individuals when exposed to other, thus far unknown environmental triggering factors. The mechanism behind the interaction between HLA and BW remains unresolved. HLA-mediated immune system alterations during the intrauterine period or molecular host responses against infectious agents, as well as altered metabolic control in mothers with hyperglycaemia or hyperinsulinaemia during pregnancy have been suggested but not proven. [21] [22] [23] A recent study showed that recurrent maternal fever and/or gastroenteritis infections during pregnancy in fact have an aggravating effect on the association between the susceptibility HLA-DQ2/8 genotype and high BW. 23 Other possible explanations are potential gene-gene interactions, that is, genes in the HLA region interact with other BW-modulating genes, or gene-environment interactions, thus far unrecognized. One may speculate, from the epigenetics point of view, that HLA [B56,DR4] or other susceptibility haplotypes may have had a selective advantage related to weight gain and thus better survival during the fetal period far in the past when food was sparse as proposed by the 'thrifty genotype' theory. 27 Nowadays, in the affluent societies, harmful effects of these diabetic haplotypes have overdrawn their previous favourable effects. Low T1D incidence rates were recorded until mid-1900s, while almost simultaneously upturn was observed in several countries since 1950. 28 T1D was no longer a deleterious disease and affected individuals have been increasingly able to reproduce and thus transmit the susceptibility haplotypes to subsequent generations.
Significantly more infants with a BW X4000 g were born in families with a T1D offspring than in the general population. Furthermore, while there has been a decreasing trend in births with a BW X4000 g in Finland, 29 in families with a T1D offspring a fluctuating pattern was observed. Furthermore, children with T1D as well as their non-diabetic siblings were found to be slightly heavier at birth than newborns in the general population, a phenomenon that has been observed also before, especially in boys. 30, 31 Except in Finland, mean BW has increased substantially in Nordic countries, 29 as well as other countries such as the United Kingdom, the United States and Canada during the last 25-year period. 32 This is largely due to the changes in numerous maternal features, such as improved nutrition and increases in maternal height, weight and gestational diabetes, higher age at delivery and reduced smoking during pregnancy. 32 That the T1D susceptibility HLA haplotypes were associated with a high BW and that an increased proportion of children with a BW X4000 g was observed in families with a T1D offspring may raise concerns because of potential adverse health effects of high BW. BW has a direct and graded association with the risk of T1D 14 and also with childhood obesity. 33 Children whose BW is X4000 g have a 50% higher risk to become overweight at the age of 6-13 years compared with those with a BW between 3000 and 3500 g. 34 Both high BW and childhood obesity are risk factors for T1D. 14, 15, 35 Overweight and obesity have increased among Finnish adolescents, especially in boys, 36 and also worldwide since the 1970s. 37 At the same time, a steep increase in T1D incidence has been observed in Finland and many other countries, in particular in the youngest age groups. 2, 3 The prevalence of overweight, measured by BMI at or above the 85th percentile, among 12-year-old Finnish boys (19.0%) and girls (12.6%) 36 was one of the highest in Europe in 1999.
38 Among 14-year-old Finnish children, the proportion of overweight was somewhat smaller (16.9% in boys and 10.0% in girls). 36 In Finnish children, increase in weight has concentrated at the upper end of the BMI distribution, suggesting that factors behind this development have influenced only a part of the adolescent population. 36 As often suggested, 14, 19, 30, 35 enhanced insulin secretion may be the causative link between T1D risk and high BW. The assumption is plausible for many reasons: insulin is the most important growth factor late in pregnancy, when the fetus has the fastest growth and development. 39 Increased insulin secretion is a hallmark of enhanced growth also later on in infancy and childhood. It has been shown experimentally 14, 30, 35 that actively insulin-secreting pancreatic b-cells express more T1D-associated antigens and are more prone to autoimmune damage and apoptosis induced by various cytokines. 40 Increased BW caused by genetic or environmental factors may contribute to the subsequent overload of b-cells, which is further accelerated by rapid linear growth and weight gain after birth, which is also known to predispose to T1D. 30, 35, 41 Accelerated growth, obesity and decreased physical activity are associated with insulin resistance, which in turn leads to hyperfunction of b-cells. 35, 42 Children who later on develop T1D are often overweight and taller compared to healthy children already in early childhood, 35, 43 and insulin resistance is also observed among young, overweight children. 44 Can the observed BW differences between families with a T1D offspring and the general population be explained by mere T1D contributing haplotypes? The [A2,Cw1,B56,DR4,DQ8] haplotype is relatively rare in Finland, whereas the susceptibility haplotypes [B8,DR3], [B62,DR4] and [B39,DR4] are more common also in the general population. 5, 6, 45 Maternal age of 35 years or above is known to increase BW 32 as well as the risk of developing T1D in the offspring. 46 The proportion of parturients aged 35 years or above has increased over time and is now 19.0% in Finland. 29 In the present study, the age distribution however did not differ between the mothers with a T1D offspring and the reference mothers 47 (data not shown). Another possible explanation might exist in sociodemographic factors, but no differences in these have been observed between families with a T1D offspring and the general population in Finland, either. 30 Hence, contribution of genetic factors, whether those located at the HLA region or some other growth-modifying loci, seems to be real to the observed BW differences between the families with a T1D offspring and the general population.
Strengths of the present study include the information on parental origin of the HLA alleles, registry linkage via the unique personal identification number, the inclusion of study subjects drawn from the databases with almost complete population coverage and the high data quality of the Medical Birth Registry. 48 Furthermore, our sample comprised children with T1D and their non-diabetic siblings, who on average share half of their genes. Hence, it was enriched by T1D susceptibility HLA genes and thus useful in testing the hypothesis whether there is an association between T1D-associated HLA haplotypes and BW. Thus, our data are based on empirically obtained data without extrapolations.
A relatively small sample size compared to previous studies 17, [21] [22] [23] [24] [25] is one of the limitations of this study. The association of HLA and BW was not compared between children with T1D and their non-diabetic siblings due to a small sample size and thereby limited statistical power to detect possible associations of HLA and BW. For HLA genotyping, we selected children born at gestational weeks 37À42, which may favour higher BW. However, in the general Finnish population, 94% of babies are born between 37 and 42 weeks of gestation. 47 Instead of age-and sex-matched control subjects recruited from general population, national reference data were used, 26 which adds to statistical power and avoids any bias. We are aware of the potential restrictions associated with the use of the data based on a relatively small sample size, but due to the exploratory nature of the study rather than testing a specific hypothesis, these data may be sufficient. This was clearly proven with the results showing that T1D-associated HLA haplotypes that had been found to have the strongest effects on T1D risk were also associated with higher BW. Despite the fact that we excluded families with mothers with diabetes, there is a small possibility that some children were born to mothers with undiagnosed gestational diabetes in this sample, which may cause minor bias. However, their proportion is extremely small compared to that in the general population. 49 In Finland, virtually all pregnant women attend antenatal clinics and are tested for gestational diabetes. In addition, BW is influenced by many biological, medical and socioeconomic factors, of which information was not available and thus could, unfortunately, not be adjusted in this study. It is worth noting that previous observations of HLA genotypes and BW have been derived from essentially different types of studies: studies including T1D cases only, non-diabetic children and children with T1D parent or children born to healthy mothers. Comparing results from these studies with the present one is not very easy. Yet, the evidence as to how HLA genes are causally linked to the development of T1D has remained completely unexplained. If the origins are indeed in fetal life, as our results indicate, studies in patients with T1D and maybe even those in infants might have been too late to detect the initial events leading to the disease onset. Obviously, more attention should be placed to fetal and even preconception periods.
In conclusion, an association between high BW and the population-specific T1D susceptibility HLA haplotype [A2,Cw1,B56,DR4,DQ8] was found in Finnish families with a T1D offspring. It seems evident that HLA genes have a modulating effect on BW. We suggest that previous associations between higher BW and increased T1D risk may partly be mediated through the possible effect HLA genes have on BW.
Patients and methods
Study population
The children and their family members included in the present study were part of the prospective, populationbased study, which aims at identifying T1D susceptibility genes and their interactions in Finland. Informed consent was obtained from all the participants (or from parents, if minor), and the study was approved by the National Ethical Committee.
A total of 1302 children comprising those diagnosed with T1D and their non-diabetic siblings born during 1987À1999 were identified through the Prospective Childhood Diabetes Database of Finland. The data were linked to the Medical Birth Registry of Finland using the unique personal identity number that is assigned to all residents of Finland. The Birth Registry includes the information on BW, gestational age, maternal age at delivery, maternal parity and other perinatal factors for all births in Finland since 1987.
Since diabetes in the mother often affects fetal growth, we excluded children born to mothers with diabetes or gestational diabetes, and those with missing BW information. Thus, the final study sample comprised 694 children with T1D and their 561 non-diabetic siblings. The comparison of the proportion of infants with a BW X4000 g between families with diabetic offspring and general population was based on this sample of 1255 individuals.
Children born prematurely display different growth patterns than those born full-term. Therefore, we further excluded children born preterm or after 42 weeks of gestation, as well as twins and half-siblings. From the remaining individuals, a proband in each family and a non-diabetic, same-sex sibling born after the proband were finally selected for HLA genotyping. A total of 171 children with T1D, 171 non-diabetic siblings and their non-diabetic parents were HLA genotyped.
DNA isolation and HLA genotyping Genomic DNA was isolated in a collaboration laboratory in Cambridge, UK. In Finland, when necessary, DNA was isolated from frozen blood using a QIAamp DNA Blood Maxi Kit (QIAGEN GmbH, Hilden, Germany) following the protocol of the kit with slight modifications.
HLA genotyping was performed using sequencespecific primers for HLA-DR and B loci (Dynal AllSet þ SSP, Dynal Biotech Ltd, Bromborough, UK). Additional HLA-A, Cw and DQ loci were typed for samples being positive for HLA-B56 and DR4 to determine whether they had the population-specific HLA haplotype [A2,Cw1,B56,DR4,DQ8]. DNA samples for PCR amplification were prepared following the protocol of the kit with slight modifications.
Statistical methods
Generalized linear analyses were used to assess association between BW and HLA. Data were adjusted for maternal age at delivery, sex and diabetes status. To study whether the association was different in children with T1D and their non-diabetic siblings, an interaction term between HLA genotype and the diabetes status was included in the model. BW was divided into three groups (2320À3479, 3480À3899 and 3900À5050 g) for descriptive purposes, but in the main analyses it was used as a continuous variable. The Cochran-Armitage test was applied for the trend in the proportion of children with a BW X4000 g in the study families and in the general population during the period 1987À1999. When we compared BWs between families with a T1D offspring and the general Finnish population, the Nordic Perinatal Statistics 2003, from the National Research and Development Centre for Welfare and Health, was used as the national reference data. 26 A P-value o0.05 was considered to be statistically significant. Statistical analyses were performed with SAS/STAT program (release 8.2, SAS Institute Inc., Cary, NC, USA).
